Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
10/14/1997 | US5677281 Use of peptide derivatives for the preparation of medicaments inhibiting endopeptidases 24.15 and 24.16 |
10/14/1997 | US5677277 Brain disorders |
10/14/1997 | CA2090423C Method of preparing diacetyl rhein |
10/09/1997 | WO1997037026A1 Novel compounds |
10/09/1997 | WO1997036927A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
10/09/1997 | WO1997036919A2 Cytokine designated lerk-8 |
10/09/1997 | WO1997036906A1 Heterocyclic compounds and their preparation and use |
10/09/1997 | WO1997036903A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
10/09/1997 | WO1997036901A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036900A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036898A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036897A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036896A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036891A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036890A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036889A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036888A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036886A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036874A1 Eprosartan dihydrate and a process for its production and formulation |
10/09/1997 | WO1997036871A1 6-phenylpyridyl-2-amine derivatives |
10/09/1997 | WO1997036867A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
10/09/1997 | WO1997036861A1 Meta-substituted phenylene sulphonamide derivatives |
10/09/1997 | WO1997036860A1 Cinnamic acid derivatives and their use as integrin antagonists |
10/09/1997 | WO1997036859A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
10/09/1997 | WO1997036858A1 Cyclopropyl alkanoic acid derivatives |
10/09/1997 | WO1997036853A1 Dimethyl-substituted cyclohexane diene derivatives |
10/09/1997 | WO1997036609A2 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest |
10/09/1997 | WO1997036605A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036594A1 Vitamin b2-containing medicines |
10/09/1997 | WO1997036593A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036592A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036591A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036585A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | WO1997036547A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins |
10/09/1997 | WO1997036497A2 Cocoa extract compounds and methods for making and using the same |
10/09/1997 | WO1997036479A1 Antibiotic cocktail and method of use |
10/09/1997 | WO1997031941A3 Soluble tachykinin antagonists, the preparation and use thereof |
10/09/1997 | WO1997026912A3 Anti-cd18 antibodies for use against stroke |
10/09/1997 | CA2250936A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2250843A1 Heterocyclic compounds and their preparation and use |
10/09/1997 | CA2250698A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
10/09/1997 | CA2250695A1 Cyclopropyl alkanoic acid derivatives |
10/09/1997 | CA2250690A1 Cinnamic acid derivatives and their use as integrin antagonists |
10/09/1997 | CA2250587A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2250353A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2250209A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
10/09/1997 | CA2250204A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2250190A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2250154A1 Dimethyl-substituted cyclohexane diene derivatives |
10/09/1997 | CA2249665A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249650A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249645A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249641A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249617A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249607A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249605A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249604A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249603A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
10/09/1997 | CA2249599A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249559A1 Inhibitors of farnesyl-protein transferase |
10/09/1997 | CA2249459A1 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
10/09/1997 | CA2248856A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins |
10/08/1997 | EP0799828A2 Pyrimido [1,2-a] indoles |
10/08/1997 | EP0799209A1 Novel sulfonamides |
10/08/1997 | EP0799206A1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists |
10/08/1997 | EP0799200A1 Substituted azetidin-2-ones for treatment of atherosclerosis |
10/08/1997 | EP0799198A1 Anti-inflammatory compounds |
10/08/1997 | EP0799189A1 Bicyclic fibrinogen antagonists |
10/08/1997 | EP0799188A2 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor |
10/08/1997 | EP0799052A1 New antithrombotic formulation, process for its manufacturing, and use thereof |
10/08/1997 | EP0799033A1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
10/08/1997 | EP0655062B1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
10/08/1997 | EP0584222B1 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
10/08/1997 | CN1161696A Heterocycle substituted propenoic acid derivatives as NMDA antagonists |
10/08/1997 | CN1161695A Apolioprotein-B synthesis inhibitors |
10/08/1997 | CN1161328A Aminoalkyl subsetd. benzo-heterocyclic compounds |
10/08/1997 | CN1036064C Method for preparing benzene derivatives with activity for improving the growth of NGF |
10/07/1997 | US5675027 Intermediates for making 4- (2-benzothiazolyl)methylamino!-α- (3, 4-difluorophenoxy)methyl!-1-piperidineethanol |
10/07/1997 | US5675008 Excitatory amino acid receptor antagonists |
10/07/1997 | US5674909 For treatment of cardiovascular disorders |
10/07/1997 | US5674894 Amidine derivatives useful as platelet aggregation inhibitors and vasodilators |
10/07/1997 | US5674893 Method for preventing reducing or risk of onset of cerebrovascular events employing an HMG CoA reductase inhibitor |
10/07/1997 | US5674890 Compounds bearing sulphamoyl and amidino radicals, their preparation process and pharmaceutical compositions containing them |
10/07/1997 | US5674884 For treatment of serotonin-related disorders |
10/07/1997 | US5674881 Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present |
10/07/1997 | US5674862 Methods of treating diabetic mellitus and its complications |
10/07/1997 | US5674836 Hypertensive agents |
10/07/1997 | US5674834 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
10/07/1997 | US5674710 Recombinant techniques for production of human brain natriuretic peptide |
10/07/1997 | CA2041380C Use of protein c or activated protein c for preparing a pharmaceutical preparation |
10/07/1997 | CA2015730C Esters of phenylalkanoic acid |
10/04/1997 | CA2201434A1 Novel pyrimido[1,2-a¦indoles |
10/02/1997 | WO1997035982A2 Monocyte chemotactic protein-5 materials and methods |
10/02/1997 | WO1997035974A1 Sequences ahead of gene sm22, vectors containing same, and therapeutical uses thereof, particularly for treating vascular diseases |
10/02/1997 | WO1997035873A2 Peptides with antiproliferative properties |
10/02/1997 | WO1997035864A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin |
10/02/1997 | WO1997035858A1 4-[(THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING α2-ADRENOCEPTOR AGONISTIC ACTIVITY |
10/02/1997 | WO1997035857A1 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity |
10/02/1997 | WO1997035856A1 Novel treatment for cns injuries |
10/02/1997 | WO1997035855A1 Novel treatment for cns injuries |